RTTR - Ritter Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
11,230
11,366
2,874
13,292
2,260
Selling General and Administrative
5,263
5,629
5,028
5,154
6,648
Total Operating Expenses
16,493
16,996
7,902
18,447
8,908
Operating Income or Loss
-16,493
-16,996
-7,902
-18,447
-8,908
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-2
1
80
Income Before Tax
-16,313
-16,869
-7,864
-18,385
-8,788
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-16,313
-16,869
-7,864
-18,385
-8,788
Net Income
-16,313
-16,869
-7,864
-18,385
-8,788
Net Income available to common shareholders
-18,851
-19,407
-10,975
-18,385
-9,179
Reported EPS
Basic
-
-3.66
-5.00
-20.40
-31.10
Diluted
-
-3.66
-5.00
-20.40
-31.10
Weighted average shares outstanding
Basic
-
5,305
2,215
899
295
Diluted
-
5,305
2,215
899
295
EBITDA
-
-16,990
-7,897
-18,442
-8,906